Core Viewpoint - The recent ratings from seven authoritative institutions highlight that GF Fund has achieved significant recognition, with 103 of its products receiving five-star ratings, showcasing its strong research capabilities and diverse product offerings [1][2]. Group 1: Active Equity Products - Nearly half of GF Fund's five-star rated funds are active equity products, characterized by diverse styles and features [2]. - Notable products include GF Value Core A, which has effectively captured trends in new consumption and internet technology, earning five-star ratings from multiple institutions [2]. - GF Fund has standout products in various sectors, such as GF North Exchange Selected Fund, which received a three-year five-star rating from several institutions [2]. Group 2: Fixed Income Products - GF Fund has over 30 fixed income funds rated five stars, covering a range of types including money market, short-term pure debt, and mixed debt funds, catering to investors' demand for stable returns [2]. Group 3: Passive Index Funds - GF Fund offers a variety of investment tools, with 24 passive index funds and 4 passive bond index funds achieving five-star ratings [3]. - The GF CSI All-Share Medical and Health ETF has received five-star ratings across three, five, and ten-year periods from two institutions [3]. Group 4: Overseas and Multi-Asset Investment - GF Fund's active and passive QDII products are recognized as representative five-star funds in overseas investments [3]. - The GF Stable Pension (FOF) A has been awarded a five-year five-star rating, reflecting its multi-asset allocation strategy [3]. Group 5: Product Management and Quality Improvement - GF Fund has integrated customer profit experience into its product creation and management processes, aiming to enhance product quality and transition from a "product manager" to a "value creator" [3].

Group 1 - Jilin Aodong (000623.SZ) reported its 2024 annual results on April 23, 2025, with 235 institutional investors holding a total of 414 million shares, representing 34.58% of the total share capital [1] - The top ten institutional investors collectively hold 31.95% of the shares, with a decrease of 6.05 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, one public fund increased its holdings, while eight funds decreased their holdings, with a reduction rate of 0.33% [2] - A total of 219 new public funds were disclosed this period, including several major ETFs [2] - One foreign fund, Hong Kong Central Clearing Limited, reduced its holdings by 0.31% compared to the previous quarter [2]

Group 1 - Tonghua Golden Horse (000766.SZ) released its 2024 annual report on April 18, 2025, with 67 institutional investors holding a total of 90.27 million A-shares, accounting for 9.34% of the total share capital [1] - The top ten institutional investors collectively hold 8.90% of the shares, with a decrease of 2.13 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, one fund, namely Innovation Drug, increased its holdings by 0.27%, while another fund, Southern CSI 1000 ETF, decreased its holdings by 0.35% [2] - A total of 62 new public funds were disclosed this period, including major funds like Huaxia CSI 1000 ETF and GF Innovation Drug ETF [2] - One foreign institution, Hong Kong Central Clearing Limited, was not disclosed in this period compared to the previous quarter [2]

Core Viewpoint - CITIC Securities has made significant adjustments to its ETF holdings, increasing positions in certain ETFs while reducing others, indicating a strategic shift in investment focus towards specific sectors and market segments [1][9]. Group 1: ETF Holdings Overview - CITIC Securities holds the largest position in the Huaxia SSE 50 ETF with a market value of 2 billion yuan, despite a reduction of 50.91 million shares [2][3]. - The second largest holding is the Huaxia CSI A500 ETF, valued at 1.846 billion yuan, reflecting a stable investment strategy as no changes in holdings were reported [2][3]. - The Southern CSI 1000 ETF has seen an increase of 25.51 million shares, indicating a focus on small-cap stocks, which are expected to perform well in the current market environment [2][4]. Group 2: Increases in Holdings - The Southern CSI 1000 ETF was increased by 255 million shares, highlighting CITIC Securities' positive outlook on small-cap stocks and emerging industries [4][5]. - The Tianhong CSI Bank ETF was increased by 6.534 million shares, reflecting confidence in the banking sector amid a favorable macroeconomic environment [5][6]. - The E-Fund SSE 50 ETF saw an increase of 4.492 million shares, emphasizing the importance of large-cap blue-chip stocks in the investment strategy [5][6]. Group 3: Reductions in Holdings - CITIC Securities reduced its holdings in the Southern CSI 500 ETF by 860 million shares, indicating caution towards mid-cap stocks due to potential market uncertainties [7][8]. - The Huaxia SSE 50 ETF also experienced a reduction of 509 million shares, suggesting a strategic shift in focus away from large-cap stocks [7][8]. - The Southern MSCI China A50 ETF was reduced by 261 million shares, further reflecting a cautious approach to blue-chip stocks in the current market context [7][8]. Group 4: New Entrants and Exits - CITIC Securities entered the top ten holders of 46 new non-cash ETFs, indicating a diversification strategy to capture various market opportunities [9][10]. - The firm exited the top ten holders of the Hai Fu Tong SSE Urban Investment Bond ETF, Southern CSI 300 ETF, and the China Merchants CSI Dividend ETF, marking a significant portfolio adjustment [14][15].